(SGI) Somnigroup International - Overview
Sector: Consumer Cyclical | Industry: Furnishings, Fixtures & Appliances | Exchange: NYSE (USA) | Market Cap: 14.070m USD | Total Return: 9.3% in 12m
Avg Turnover: 203M
EPS Trend: 83.5%
Qual. Beats: 0
Rev. Trend: 86.7%
Qual. Beats: 0
Warnings
Fakeout
Tailwinds
No distinct edge detected
Somnigroup International Inc. (NYSE: SGI), formerly Tempur Sealy International, Inc., is a global designer, manufacturer, and retailer of bedding products. The company manages a vertically integrated supply chain, producing mattresses, adjustable foundations, and accessories under premium brands including Tempur-Pedic, Sealy, and Stearns & Foster. Its distribution network spans company-owned retail stores, e-commerce platforms, and third-party partnerships across the hospitality and healthcare sectors.
The bedding industry is characterized by high capital expenditures and cyclical consumer demand, with recent trends shifting toward direct-to-consumer digital sales and specialized orthopedic technologies. Somnigroup utilizes a multi-brand strategy to target various price points, from luxury memory foam to traditional innerspring units. For a deeper look into the companys fundamental metrics, ValueRay provides comprehensive data analysis. Headquartered in Dallas, Texas, the firm maintains a significant intellectual property portfolio through the licensing of its trademarks and proprietary manufacturing processes to international partners.
- Mattress Firm acquisition synergy realization drives long-term retail margin expansion
- High interest rates dampen housing turnover and durable goods demand
- Direct-to-consumer sales growth offsets declining third-party wholesale distribution volume
- Raw material cost fluctuations impact manufacturing overhead and gross profitability
- FTC antitrust scrutiny of retail consolidation poses significant regulatory execution risk
| Net Income: 521.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.50 > 1.0 |
| NWC/Revenue: -4.70% < 20% (prev -5.03%; Δ 0.33% < -1%) |
| CFO/TA 0.08 > 3% & CFO 940.2m > Net Income 521.4m |
| Net Debt (8.41b) to EBITDA (1.22b): 6.89 < 3 |
| Current Ratio: 0.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (212.6m) vs 12m ago 6.89% < -2% |
| Gross Margin: 44.37% > 18% (prev 0.42%; Δ 4.40k% > 0.5%) |
| Asset Turnover: 67.11% > 50% (prev 47.19%; Δ 19.92% > 0%) |
| Interest Coverage Ratio: 3.54 > 6 (EBITDA TTM 1.22b / Interest Expense TTM 266.6m) |
| A: -0.03 (Total Current Assets 1.25b - Total Current Liabilities 1.61b) / Total Assets 11.5b |
| B: 0.34 (Retained Earnings 3.90b / Total Assets 11.5b) |
| C: 0.08 (EBIT TTM 944.5m / Avg Total Assets 11.4b) |
| D: 0.45 (Book Value of Equity 3.79b / Total Liabilities 8.38b) |
| Altman-Z'' = 1.93 = BBB |
| DSRI: 0.69 (Receivables 339.1m/341.8m, Revenue 7.67b/5.35b) |
| GMI: 0.95 (GM 44.37% / 42.05%) |
| AQI: 1.02 (AQ_t 0.64 / AQ_t-1 0.63) |
| SGI: 1.44 (Revenue 7.67b / 5.35b) |
| TATA: -0.04 (NI 521.4m - CFO 940.2m) / TA 11.5b) |
| Beneish M = -3.04 (Cap -4..+1) = AA |
As of May 31, 2026, the stock is trading at USD 70.81 with a total of 2,827,586 shares traded.
Over the past week, the price has changed by +5.28%,
over one month by -5.57%,
over three months by -20.53% and
over the past year by +9.30%.
Somnigroup International has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy SGI.
- StrongBuy: 7
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 97.3 | 37.3% |
P/E Trailing = 26.756
P/E Forward = 22.4719
P/S = 1.8336
P/B = 4.4703
P/EG = 0.8336
Revenue TTM = 7.67b USD
EBIT TTM = 944.5m USD
EBITDA TTM = 1.22b USD
Long Term Debt = 4.44b USD (from longTermDebt, last quarter)
Short Term Debt = 512.8m USD (from shortTermDebt, last quarter)
Debt = 8.52b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.99b
Net Debt = 8.41b USD (calculated: Debt 8.52b - CCE 110.8m)
Enterprise Value = 22.5b USD (14.1b + Debt 8.52b - CCE 110.8m)
Interest Coverage Ratio = 3.54 (Ebit TTM 944.5m / Interest Expense TTM 266.6m)
EV/FCF = 30.51x (Enterprise Value 22.5b / FCF TTM 736.8m)
FCF Yield = 3.28% (FCF TTM 736.8m / Enterprise Value 22.5b)
FCF Margin = 9.60% (FCF TTM 736.8m / Revenue TTM 7.67b)
Net Margin = 6.79% (Net Income TTM 521.4m / Revenue TTM 7.67b)
Gross Margin = 44.37% ((Revenue TTM 7.67b - Cost of Revenue TTM 4.27b) / Revenue TTM)
Gross Margin QoQ = 43.61% (prev 44.93%)
Tobins Q-Ratio = 1.95 (Enterprise Value 22.5b / Total Assets 11.5b)
Interest Expense / Debt = 3.13% (Interest Expense 266.6m / Debt 8.52b)
Taxrate = 24.33% (33.4m / 137.3m)
NOPAT = 714.7m (EBIT 944.5m * (1 - 24.33%))
Current Ratio = 0.78 (Total Current Assets 1.25b / Total Current Liabilities 1.61b)
Debt / Equity = 2.71 (Debt 8.52b / totalStockholderEquity, last quarter 3.15b)
Debt / EBITDA = 6.89 (Net Debt 8.41b / EBITDA 1.22b)
Debt / FCF = 11.41 (Net Debt 8.41b / FCF TTM 736.8m)
Total Stockholder Equity = 3.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.56% (Net Income 521.4m / Total Assets 11.5b)
RoE = 17.26% (Net Income TTM 521.4m / Total Stockholder Equity 3.02b)
RoCE = 12.67% (EBIT 944.5m / Capital Employed (Equity 3.02b + L.T.Debt 4.44b))
RoIC = 6.92% (NOPAT 714.7m / Invested Capital 10.3b)
WACC = 7.11% (E(14.1b)/V(22.6b) * Re(9.98%) + D(8.52b)/V(22.6b) * Rd(3.13%) * (1-Tc(0.24)))
Discount Rate = 9.98% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 84.11 | Cagr: 8.16%
[DCF] Terminal Value 77.97% ; FCFF base≈663.2m ; Y1≈760.3m ; Y5≈1.12b
[DCF] Fair Price = 40.07 (EV 16.8b - Net Debt 8.41b = Equity 8.43b / Shares 210.3m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 83.50 | EPS CAGR: 4.59% | SUE: -0.34 | # QB: 0
Revenue Correlation: 86.72 | Revenue CAGR: 23.21% | SUE: -0.01 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.57 | Chg30d=-17.66% | Revisions=-57% | Analysts=10
EPS next Quarter (2026-09-30): EPS=1.13 | Chg30d=+0.32% | Revisions=-9% | Analysts=10
EPS current Year (2026-12-31): EPS=3.15 | Chg30d=-3.11% | Revisions=-54% | GrowthEPS=+16.8% | GrowthRev=+4.3%
EPS next Year (2027-12-31): EPS=3.91 | Chg30d=-3.28% | Revisions=-50% | GrowthEPS=+23.8% | GrowthRev=+4.8%
[Analyst] Revisions Ratio: -57%